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PAG/Cbp (hereafter named PAG) is a transmembrane adaptor molecule found in lipid rafts. In resting
human T cells, PAG is tyrosine phosphorylated and associated with Csk, an inhibitor of Src-related protein
tyrosine kinases. These modifications are rapidly lost in response to T-cell receptor (TCR) stimulation.
Overexpression of PAG was reported to inhibit TCR-mediated responses in Jurkat T cells. Herein, we have
examined the physiological relevance and the mechanism of PAG-mediated inhibition in T cells. Our studies
showed that PAG tyrosine phosphorylation and association with Csk are suppressed in response to activation
of normal mouse T cells. By expressing wild-type and phosphorylation-defective (dominant-negative) PAG
polypeptides in these cells, we found that the inhibitory effect of PAG is dependent on its capacity to be tyrosine
phosphorylated and to associate with Csk. PAG-mediated inhibition was accompanied by a repression of
proximal TCR signaling and was rescued by expression of a constitutively activated Src-related kinase,
implying that it is due to an inactivation of Src kinases by PAG-associated Csk. We also attempted to identify
the protein tyrosine phosphatases (PTPs) responsible for dephosphorylating PAG in T cells. Through cell
fractionation studies and analyses of genetically modified mice, we established that PTPs such as PEP and
SHP-1 are unlikely to be involved in the dephosphorylation of PAG in T cells. However, the transmembrane
PTP CD45 seems to play an important role in this process. Taken together, these data provide firm evidence
that PAG is a bona fide negative regulator of T-cell activation as a result of its capacity to recruit Csk. They
also suggest that the inhibitory function of PAG in T cells is suppressed by CD45. Lastly, they support the idea
that dephosphorylation of proteins on tyrosine residues is critical for the initiation of T-cell activation.
T-cell activation is initiated by the interaction of the T-cell
receptor (TCR) for antigens with antigenic peptides com-
plexed to major histocompatibility complex molecules (37).
TCR engagement by antigens triggers the tyrosine phosphor-
ylation of a short sequence, the immunoreceptor tyrosine-
based activation motif, present in the TCR-associated CD3-
subunits (7, 23). Such immunoreceptor tyrosine-based activa-
tion motifs function by orchestrating the sequential activation
of the Src-related protein tyrosine kinases (PTKs) Lck and
FynT, which initiate TCR signaling, followed by that of the
Zap-70/Syk PTKs, which amplify the response (7). These var-
ious PTKs induce tyrosine phosphorylation of several polypep-
tides, including the transmembrane adaptor LAT, the adaptor
SLP-76, and enzymatic effectors such as phospholipase C
(PLC)- (9, 24, 27, 28). Protein tyrosine phosphorylation sub-
sequently leads to the activation of several other signaling
pathways, which ultimately induce effector functions.
PAG (phosphoprotein associated with glycosphingolipid-en-
riched microdomains), or Cbp (Csk-binding protein), is an
80-kDa transmembrane protein expressed in all cell types,
including T cells (2, 20). It possesses a short extracellular
domain (16 to 18 amino acids), a single transmembrane seg-
ment, and a long intracytoplasmic domain bearing multiple
tyrosine-based motifs (9 in mouse PAG and 10 in human
PAG). Interestingly, PAG/Cbp (hereafter termed PAG) is
concentrated in membrane microdomains referred to as lipid
rafts. These microdomains are rich in signaling molecules such
as Src-related PTKs, LAT, G proteins, and glycophosphatidyl
inositol-linked receptors and are proposed to play an impor-
tant role in cell signaling (19, 23).
Previous studies revealed that PAG is tyrosine phosphory-
lated in unstimulated human T cells, seemingly as a result of
the action of Src kinases (2, 32). This phosphorylation is ac-
companied by the association of PAG with significant amounts
of Csk, a Src homology 2 (SH2) domain-bearing cytoplasmic
PTK expressed ubiquitously (23, 30, 35). Interestingly, PAG
becomes rapidly dephosphorylated and is dissociated from Csk
in response to activation of human T cells (2, 17, 32). Since Csk
inhibits Src-related enzymes by phosphorylating their inhibi-
tory tyrosine [tyrosine (Y) 505 in Lck; Y528 in FynT], it was
proposed that PAG might mediate a negative signal in lipid
rafts which is aimed at preventing or terminating T-cell acti-
vation. In support of this idea, transient overexpression of
PAG was reported to cause an inhibition (2-fold) of TCR-
mediated activation of nuclear factor of activated T cells and
interleukin-2 (IL-2) production in Jurkat T cells (2, 17).
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Whether a similar inhibitory function exists for endogenous
PAG molecules expressed in normal T cells was not estab-
lished.
The mechanism of PAG-mediated inhibition remains to be
clarified. While inactivation of Src kinases by PAG-associated
Csk molecules is a plausible explanation, other possibilities
exist. Along these lines, it is noteworthy that the cytoplasmic
domain of PAG bears several protein-protein interaction mo-
tifs, including the aforementioned tyrosines, proline-rich mo-
tifs, and a carboxyl-terminal PDZ-binding sequence. While
one of the tyrosines, tyrosine 314 in mouse PAG, was reported
to be responsible for Csk binding in transiently transfected Cos
cells, there is evidence that one or more other tyrosines are
also phosphorylated (2, 20). These residues might mediate the
binding of additional SH2 domain-bearing molecules, thus al-
lowing recruitment of other inhibitory effectors to PAG. PAG
also bears several proline-rich sequences in its cytoplasmic
regions, which might permit binding of SH3 domain-contain-
ing molecules. Lastly, the PDZ-binding motif of PAG was
reported to allow a physical interaction between PAG and
EBP-50, a cytoskeletal linker (3, 17). This association appears
to be critical for PAG-mediated inhibition, at least in Jurkat T
cells (17).
CD45 is a transmembrane protein tyrosine phosphatase
(PTP) abundantly expressed in all nucleated hemopoietic cells
(26, 31). Previous studies showed that CD45 expression is
required for the initiation of TCR signaling. This function is
thought to reflect the ability of CD45 to dephosphorylate the
inhibitory tyrosine of Src kinases Lck and FynT. As a conse-
quence, CD45 antagonizes the inhibitory impact of Csk,
thereby favoring T-cell activation. However, given the extreme
abundance of CD45 in T-cell membranes, it is plausible that
CD45 has additional targets that explain its permissive effect
on T-cell activation.
In this study, we attempted to elucidate the physiological
relevance and the mechanism of action of PAG in T cells. Our
data provided evidence that PAG is involved in the negative
regulation of T-cell activation in normal T cells. They also
indicated that the inhibitory effect of PAG on T-cell activation
is dependent on its ability to be tyrosine phosphorylated, to
associate with Csk, and to inactivate Src-related kinases. Fi-
nally, they suggested that CD45, but not PTPs such as PEP and
SHP-1, promotes the dephosphorylation of PAG in T cells.
This effect might help explain the functional importance of
CD45 during T-cell activation.
MATERIALS AND METHODS
Cells. The CD45-positive mouse T-cell line YAC-1 and Cos-1 cells were
obtained from the American Type Culture Collection, Rockville, Md. The CD45-
negative YAC-1 variant, YACN1 (36), was provided by Jonathan Ashwell, Na-
tional Institutes of Health, Bethesda, Md.
cDNAs and constructs. The wild-type mouse pag cDNA (EST clone AI882478)
was obtained from Genome Systems, Inc., St. Louis, Mo. Variants in which all
tyrosines in the cytoplasmic domain (9Y3F) or Y314 alone were replaced by
phenylalanines were produced using the QuikChange site-directed mutagenesis
kit (Stratagene, La Jolla, Calif.). All cDNAs were fully sequenced to ensure that
they contained no unwanted mutations (data not shown). The cDNAs coding for
constitutively activated FynT (FynT Y528F), myristylated CD45 (wild type or
phosphatase inactive [C3S]), and SH2 Y505F Lck were described elsewhere
(6, 13, 25).
Antibodies and reagents. Antibodies directed against the cytoplasmic domain
of PAG were produced in rabbits by immunization with a glutathione S-trans-
ferase fusion protein encompassing amino acids 352 to 425 of the cytoplasmic
domain of mouse PAG. In some experiments, a rabbit polyclonal antibody
directed against the cytoplasmic domain of human PAG and cross-reacting with
mouse PAG was used. Rabbit antibodies against Csk, PEP, PTP-PEST, SHP-1,
SHP-2, FynT, Lck, and phosphotyrosine (P.tyr) were generated in our labora-
tory. Antiphosphotyrosine monoclonal antibody (MAb) 4G10 was purchased
from Upstate Biotechnology Inc., Lake Placid, N.Y. Anti-LAT antibodies were
provided by Larry Samelson (National Institutes of Health, Bethesda, Md.),
while those reacting against the cytoplasmic domain of mouse CD45 were ob-
tained from Phil Branton, McGill University, Montreal, Quebec, Canada. Puri-
fied anti-CD3 MAb 145-2C11 and anti-CD28 MAb 37.51 were prepared in our
laboratory. Anti-TCR MAb H57-597, biotinylated MAb 145-2C11, and biotinyl-
ated MAb H57-597 were purchased from BD Pharmingen, Mississauga, Ontario,
Canada. Cholera toxin (B subunit) conjugated to horseradish peroxidase was
purchased from Sigma, St. Louis, Mo.
Mice. For production of PAG transgenics, pag cDNAs were cloned in the
pCD2 construct, which contains the human CD2 promoter (obtained from Dimi-
tris Kioussis, London, England). To create transgenic mice expressing constitu-
tively activated FynT, the cDNA coding for FynT Y528F was inserted into the
vector plckHGH (provided by Roger Perlmutter, University of Washington,
Seattle, Wash.) (12). This vector bears the proximal lck promoter and is active
mostly in thymocytes. Transgenic mice were produced according to established
protocols by the IRCM Transgenic Service. At least two independent founders of
each transgenic type were used in our studies. Mice lacking expression of CD45
(4) or SHP-1 (motheaten) (33) were obtained from the Jackson Laboratory, Bar
Harbor, Maine. Those lacking PEP were obtained from Matt Thomas (Wash-
ington University, St. Louis, Mo.). They were created by replacing most of the
phosphatase domain of PEP with a neomycin resistance cassette (M. Thomas,
personal communication). These mice lacked functional PEP protein and exhib-
ited no obvious defect in T-cell development.
Cell stimulation. Typically, thymocytes (30  106) were stimulated for the
indicated periods of time at 37°C with biotinylated anti-CD3 MAb 145-2C11 (10
g) or anti-TCR H57-597 (10 g) and avidin (14 g) in a volume of 200 l.
Unstimulated controls were incubated at 37°C with avidin alone. After lysis in
buffer containing maltoside (1% n-dodecyl--D-maltoside, 50 mM Tris [pH 7.6],
150 mM NaCl, 2 mM EDTA) supplemented with protease and phosphatase
inhibitors (13), postnuclear lysates were processed for immunoprecipitation or
immunoblotting. In some experiments, lysates were separated by sucrose density
gradient centrifugation (see below).
Immunoprecipitations and immunoblots. Unless specified, immunoprecipita-
tions and immunoblottings were performed according to previously described
protocols (13, 34), with the exception that maltoside-containing buffer was used.
Functional assays. Using magnetic columns (Stem Cell Technologies, Van-
couver, British Columbia, Canada), CD4 or CD8 T cells were purified from
thymus, spleen, or lymph nodes of individual mice. The purity of the cell prep-
arations was verified by flow cytometry and was consistently greater than 90%
(data not shown). Using anti-CD3 MAb 145-2C11 (1 or 3 g/ml) coated on
plastic, with or without soluble anti-CD28 MAb 37.51 (1 g/ml), T cells were
activated in vitro for 40 to 48 h. In some experiments, recombinant IL-2 (20
U/ml) was added to the culture medium. Controls were stimulated with phorbol
myristate acetate (PMA) (50 ng/ml) and ionomycin (100 ng/ml). After stimula-
tion, proliferation was measured by assaying for [3H]thymidine incorporation,
while cytokine production was revealed by enzyme-linked immunosorbent assay
(R&D Systems, Minneapolis, Minn.). All assays were done in triplicate, and
experiments were repeated at least three times.
Cell fractionation. Cells (150  106) were lysed in 1 ml of Brij 58-containing
buffer (1% Brij 58, 25 mM Tris [pH 7.6], 150 mM NaCl, 5 mM EDTA) supple-
mented with protease and phosphatase inhibitors. Lysates were then mixed with
1 ml of 80% sucrose (made in the same buffer without detergent) and overlaid
sequentially with 2 ml of 30% sucrose and 1 ml of 5% sucrose. After centrifu-
gation at 200,000 g for 16 h at 4°C, 0.5-ml fractions were collected from the top
of the gradient. Typically, fractions 2 to 4 contained the lipid rafts while fractions
7 to 10 contained the soluble proteins. Individual fractions were analyzed by
immunoblotting or immunoprecipitation, after solubilization using 1% malto-
side. In some cases, fractions were pooled prior to analysis.
Intracellular calcium fluxes. Ex vivo thymocytes (2  106) were loaded with
Indo-1 (10 M; Molecular Probes, Eugene, Oreg.) for 45 min at 37°C and stained
for 10 min at room temperature with phycoerythrin-coupled anti-CD4 and flu-
orescein-isothiocyanate-coupled anti-CD8 (purchased from BD Pharmingen).
After the cells were washed, they were stimulated at 37°C with biotinylated
anti-TCR H57-597 and avidin. Changes in intracellular calcium over time were
monitored using a cell sorter (MoFlo; Cytomation, Fort Collins, Colo.). CD4
single-positive cells were selectively analyzed by gating on CD4 CD8	 thymo-
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cytes. As control, cells were stimulated with the calcium ionophore ionomycin
(100 ng/ml).
Substrate-trapping experiment. Using Lipofectamine (Life Technologies,
Burlington, Ontario, Canada), Cos-1 cells were transfected with the indicated
cDNAs. After lysis in substrate-trapping buffer (11), lysates were processed for
immunoprecipitation and immunoblotting according to standard protocols.
RESULTS
Rapid dephosphorylation of PAG in antigen receptor-stim-
ulated mouse T cells. Previously, it was reported that PAG
tyrosine phosphorylation, as well as its association with Csk,
was rapidly reduced following activation of human T cells with
anti-CD3 antibodies (2, 17, 32). To investigate whether a sim-
ilar phenomenon exists in mouse T cells, ex vivo mouse thy-
mocytes were activated for various periods of time with bio-
tinylated anti-CD3 MAb 145-2C11 and avidin. Thymocyte
preparations were chosen for these experiments, because they
yield large numbers of pure T cells without requiring pro-
longed in vitro manipulations that can alter protein tyrosine
phosphorylation. After stimulation, cells were lysed in Brij
58-containing buffer and lysates were fractionated by sucrose
density gradient centrifugation. Following solubilization of
lipid raft fractions with maltoside, PAG was recovered by im-
munoprecipitation with a polyclonal rabbit anti-PAG serum
and its tyrosine phosphorylation was monitored by immuno-
blotting with anti-P.tyr antibodies (Fig. 1A, top panel).
This analysis showed that PAG was prominently tyrosine
phosphorylated in unstimulated thymocytes (Fig. 1A, lane 1).
By contrast, upon antigen receptor stimulation (Fig. 1A, lanes
2 to 5), PAG tyrosine phosphorylation became markedly re-
duced. Such a diminution occurred rapidly (within 1 min; Fig.
1A, lane 2) and was essentially complete by 2 min (lane 3). It
correlated temporally with the induction of overall protein
tyrosine phosphorylation in thymocyte lysates (Fig. 1B). A
similar phenomenon was observed in ex vivo splenic T cells
(data not shown). The association of PAG with Csk was also
examined (Fig. 1A, center panel). We found that significant
amounts of Csk were associated with PAG in unstimulated
mouse thymocytes (Fig. 1A, lane 1). However, this interaction
was quickly eliminated following antigen receptor stimulation
(Fig. 1A, lanes 2 to 5). Hence, these findings demonstrated that
the reduction in PAG tyrosine phosphorylation and association
with Csk seen in response to TCR engagement occurred in
normal mouse T cells.
Expression of wild-type and phosphorylation-defective PAG
molecules in normal mouse T cells. Considering these obser-
vations, we addressed further the role of PAG, and the impact
of its tyrosine phosphorylation, in the regulation of T-cell ac-
tivation. To this end, using a CD2 promoter-driven construct,
various PAG polypeptides were expressed in transgenic mice.
In addition to wild-type PAG, we studied phosphorylation-
defective PAG mutants in which either all nine tyrosines in the
cytoplasmic region, or the major Csk-binding site (Y314) alone
(2, 20, 30), were mutated to phenylalanines. The two PAG
mutants were chosen with the expectation that they might also
behave as dominant-negative molecules and help establish the
role of endogenous PAG polypeptides in T-cell functions. The
expression of dominant-negative variants of signaling mole-
cules in transgenic mice has been validated as a useful tool to
elucidate the biochemical pathways regulating T-cell activation
(5). In keeping with the fact that the CD2 promoter is active
both in immature and in mature T cells, the different PAG
polypeptides were found to be overexpressed in thymocytes,
splenic T cells, and lymph node T cells (Fig. 2A and data not
shown).
The ability of the PAG molecules to undergo tyrosine phos-
phorylation and associate with Csk was examined first (Fig. 2B
and C). We found that thymocytes overexpressing wild-type
PAG (lanes 2) contained greater amounts of tyrosine-phos-
phorylated PAG (top panels) and PAG-associated Csk (second
from the top) than control thymocytes (lanes 1). However, no
such increases were observed in thymocytes expressing PAG
Y314F (Fig. 2B, lane 3) or PAG 9Y3F (Fig. 2C, lane 3). While
a small enhancement of PAG tyrosine phosphorylation and
FIG. 1. Effect of TCR stimulation on PAG tyrosine phosphorylation and association with Csk in normal mouse T cells. (A) PAG immuno-
precipitations. Mouse thymocytes were stimulated for the indicated periods of time at 37°C with biotinylated anti-CD3 MAb 145-2C11 and avidin.
Unstimulated controls were incubated with avidin alone. Unstimulated and stimulated cells were lysed in Brij 58-containing buffer and subjected
to sucrose density gradient centrifugation. Lipid raft fractions (fractions 2 and 3) were recovered, solubilized in maltoside, and immunoprecipitated
with anti-PAG antibodies. Tyrosine phosphorylation of PAG was monitored by probing of anti-PAG immunoprecipitates with anti-P.tyr antibodies
(top panel). The association of PAG with Csk was determined by reprobing the immunoblot membrane with anti-Csk (center panel), while the
abundance of PAG was verified by reprobing with anti-PAG (bottom panel). (B) Overall protein tyrosine phosphorylation. Total cell lysates from
the experiment depicted in Fig. 1A were probed by anti-P.tyr immunoblotting.
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PAG-associated Csk was seen in thymocytes expressing the two
PAG mutants, these changes were possibly caused by an influ-
ence of the mutant PAG molecules on the phosphorylation of
the endogenous PAG polypeptides. In any case, these results
implied that Y314 is the predominant site of PAG tyrosine
phosphorylation in normal T cells and that it is critical for the
ability of PAG to recruit Csk in these cells. Whether the other
eight tyrosines in the cytoplasmic region of mouse PAG are
phosphorylated in T-lymphocytes remains to be demonstrated.
Expression of the PAG transgenes had no appreciable im-
pact on thymocyte numbers or subpopulations. Moreover, it
had no influence on the numbers or proportions of CD4 and
CD8 T cells in spleen and lymph nodes or on the levels of
TCR expression at the cell surface (data not shown).
Tyrosine 314-dependent inhibition of TCR-induced prolif-
eration and IL-2 secretion by PAG. To ascertain the impact of
PAG on TCR signaling, CD4 splenic T cells were purified
from the various mice and were stimulated with anti-CD3
alone or in combination with anti-CD28. T-cell proliferation
was then monitored by measuring the incorporation of tritiated
thymidine (Fig. 3A and B). This assay showed that overexpres-
sion of wild-type PAG caused a pronounced inhibition of thy-
midine incorporation in response to stimulation with anti-CD3
or anti-CD3 plus anti-CD28. Similar results were obtained with
CD4 thymocytes, CD4 lymph node T cells, or CD8 splenic
T cells or when anti-TCR MAb H57-597 or anti-Thy-1 anti-
body was used for stimulation (data not shown). In contrast,
expression of PAG Y314F provoked an increase in the prolif-
erative response to the presence of anti-CD3 or anti-CD3 plus
anti-CD28 (Fig. 3A). In addition to showing that the Csk-
binding site was required for the inhibitory effect of PAG, this
observation confirmed that PAG Y314F had a dominant-neg-
ative effect in T cells. A similar effect was seen with PAG
9Y3F (Fig. 3B). Importantly, the differences in TCR-medi-
ated proliferation between these various mice were not due to
global variations in cell responsiveness, as all cells responded
equally well to PMA plus ionomycin (Fig. 3A and B).
The influence of PAG expression on antigen receptor-in-
duced cytokine production was also evaluated (Fig. 3C to F).
Cells were stimulated as outlined above, and the release of
IL-2, gamma interferon (IFN-), or IL-4 in the supernatant
was monitored by enzyme-linked immunosorbent assay. These
studies revealed that wild-type PAG provoked a significant
reduction of IL-2 secretion in response to anti-CD3 or anti-
CD3 plus anti-CD28 (Fig. 3C and D). Conversely, PAG Y314F
(Fig. 3C) and PAG 9Y3F (Fig. 3D) caused an increase in IL-2
production. Intriguingly, however, PAG had no influence on
the production of IL-4 (Fig. 3E) or IFN- (Fig. 3F), even when
lower concentrations of anti-CD3 were used for stimulation
(data not shown).
Since T cells utilize IL-2 to sustain their growth, we exam-
ined whether the inhibitory effect of PAG on IL-2 secretion
was the basis for the reduction in their proliferation (Fig. 3G).
To this end, T cells were stimulated with anti-CD3 alone or in
combination with anti-CD28, in the presence or in the absence
of exogenous IL-2. Proliferation was then measured as de-
scribed earlier. We found that addition of IL-2 only partially
corrected the inhibitory effect of PAG on proliferation. Thus,
while part of the inhibitory effect of PAG on proliferation can
be ascribed to reduced IL-2 production, it is likely that addi-
tional factors are also involved.
Inhibition of proximal TCR-mediated signaling events by
PAG. To establish the biochemical mechanism responsible for
PAG-mediated inhibition, we assessed the effect of PAG on
FIG. 2. Overexpression of wild-type PAG and dominant-negative PAG mutants in transgenic mice. (A) Overexpression of PAG in various
T-cell populations. Purified T cells from normal control mice or transgenic mice overexpressing wild-type PAG (PAG wt) were probed by
immunoblotting of total cell lysates with anti-PAG. Flow cytometry analyses confirmed that 
90% of cells in all preparations were T cells (data
not shown). Similar results were obtained with transgenic mice expressing PAG Y314F and PAG 9Y3F (data not shown). (B and C) Tyrosine
phosphorylation of PAG and its association with Csk. PAG was immunoprecipitated from lipid raft fractions isolated from thymocytes of the
indicated mice, and its tyrosine phosphorylation was determined by immunoblotting with anti-P.tyr antibodies (top panels). The association of PAG
with Csk was ascertained by reprobing of the immunoblot membrane with anti-Csk (second panels from the top) or by immunoblotting of anti-Csk
immunoprecipitates with anti-PAG (third panels from the top). The abundance of PAG (fourth panels from the top) and Csk (fifth panels from
the top) was verified by immunoblotting of total cell lysates with anti-PAG and anti-Csk, respectively. Note that in Fig. 2B and C, the duration of
the autoradiographic exposures was much shorter than that used for Fig. 1A. This explains the weaker signal of PAG tyrosine phosphorylation (top
panels) and PAG-associated Csk (second panels from the top) in control thymocytes. Both immunoreactive products were more clearly seen upon
longer autoradiographic exposures (data not shown). The upper band seen in the anti-Csk immunoblots of PAG immunoprecipitates is the heavy
chain of immunoglobulin.
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FIG. 3. Impact of PAG on antigen receptor-induced proliferation and cytokine production. CD4 splenic T cells were isolated from the
indicated mice and stimulated for 40 to 48 h with medium alone, immobilized anti-CD3 alone (1 or 3 g/ml), immobilized anti-CD3 (1 or 3 g/ml)
plus soluble anti-CD28 (1 g/ml), or the combination of PMA (50 ng/ml) plus ionomycin (iono) (100 ng/ml). wt, wild type. (A and B) Thymidine
incorporation. All assays were done in triplicate, and average values are shown. (C and D) IL-2 secretion; (E) IL-4 production; (F) IFN-
production. (G) The experiment was performed as described for Fig. 3A, except that the proliferation assays were in the absence or in the presence
of recombinant IL-2 (20 U/ml). For panels C to G, all assays were done in duplicate and average values are shown.
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TCR-induced protein tyrosine phosphorylation, the earliest
event of T-cell activation (Fig. 4). Thymocytes from the various
transgenic mice were stimulated with biotinylated anti-TCR
MAb H57-597 and avidin, and the induction of protein ty-
rosine phosphorylation was monitored by immunoblotting of
total cell lysates with anti-P.tyr antibodies (Fig. 4A). We ob-
served that cells overexpressing wild-type PAG (lanes 6 to 10)
exhibited a decrease in TCR-induced protein tyrosine phos-
phorylation in comparison to cells from control mice (lanes 1
to 5). This diminished tyrosine phosphorylation involved
mostly a polypeptide of 36 kDa (p36), which was confirmed by
immunoprecipitation to be LAT, a lipid raft-associated trans-
membrane adaptor required for TCR signaling (38) (data not
shown). In addition, a less marked reduction of tyrosine phos-
phorylation of proteins of 120, 100, 76 and 70 kDa was ob-
served. In contrast to wild-type PAG, PAG Y314F (Fig. 4A,
lanes 11 to 15) had no inhibitory effect on antigen receptor-
triggered protein tyrosine phosphorylation. However, in all
experiments, this mutant had a small stimulatory effect on the
tyrosine phosphorylation of LAT (for example, compare lanes
3 through 5 to lanes 13 through 15; data not shown). Similar
results were obtained with PAG 9Y3F (data not shown).
In addition to the induction of intracellular protein tyrosine
phosphorylation events, TCR stimulation resulted in the de-
phosphorylation of an 80-kDa tyrosine-phosphorylated sub-
strate, most evident in thymocytes overexpressing wild-type
PAG (Fig. 4A, lanes 6 to 10). This product, which represented
PAG (data not shown), was detectable in unstimulated cells
(lane 6) but disappeared within 1 min of TCR stimulation (lane
7). Interestingly, such a decrease seemed to precede the induc-
tion of overall protein tyrosine phosphorylation by TCR stim-
ulation.
Because PAG is primarily located in lipid rafts (2, 20), we
wanted to exclude the possibility that its overexpression was
inhibiting TCR signaling simply by displacing LAT from the
rafts (Fig. 4B). To this end, cells were activated as described
above but were lysed in Brij 58-containing buffer. Lysates were
subsequently fractionated by sucrose density gradient centrif-
ugation, and aliquots from lipid raft (fractions 2 and 3) and
soluble (fractions 8 and 9) fractions were probed by anti-P.tyr
(Fig. 4B, top panel) or anti-LAT (center panel) immunoblot-
ting. As expected, PAG overexpression caused a decrease in
p36/LAT tyrosine phosphorylation in the lipid rafts (top panel;
compare lanes 2 and 5). Importantly, however, reprobing with
anti-LAT antibodies showed that this diminution was not due
to a reduction of the abundance of LAT in the rafts (center
panel).
In addition to the decrease in lipid raft-associated p36/LAT
tyrosine phosphorylation, PAG overexpression provoked a re-
duction of the tyrosine phosphorylation of polypeptides found
solely in the soluble fractions, such as p120 (Fig. 4B; compare
lanes 8 and 11). This finding indicated that PAG was able to
inhibit protein tyrosine phosphorylation not only inside but
also outside the rafts. It is possible that this effect was caused
by the pool of PAG molecules (20% of total) situated in the
soluble fractions (bottom panel, lanes 7 to 12). However, be-
cause PAG tyrosine phosphorylation occurred exclusively in-
side the rafts (top panel, lanes 1 to 6), it seems more plausible
that this inhibition was also effected by the raft-associated
PAG.
Next, we tested the effect of PAG on TCR-induced calcium
fluxes, a proximal signaling event known to be highly depen-
dent on LAT tyrosine phosphorylation (27) (Fig. 5). Thymo-
cytes were loaded with the calcium indicator dye Indo-1 and
were stimulated with biotinylated anti-TCR MAb H57-597 and
avidin. Changes in levels of intracellular calcium over time
were subsequently monitored in CD4 single-positive thymo-
cytes by flow cytometry. This analysis showed that compared to
normal cells (Fig. 5A), T cells overexpressing wild-type PAG
(Fig. 5B) exhibited a pronounced reduction of the TCR-in-
duced increase in intracellular calcium levels. In contrast, T
cells expressing PAG Y314F (Fig. 5C) demonstrated a more
sustained calcium signal than control thymocytes (Fig. 5A).
Nonetheless, all cells responded equally well to the calcium
ionophore ionomycin (data not shown). Since wild-type PAG
and PAG Y314F influenced calcium fluxes within a few min-
utes of TCR stimulation, these results further supported the
notion that PAG acted proximally on the TCR signaling cas-
cade. Moreover, they implied that the small increase in LAT
tyrosine phosphorylation seen in cells expressing PAG Y314F
(Fig. 4A and data not shown) was likely to be biologically
significant.
Rescue of PAG-mediated inhibition by a constitutively acti-
FIG. 4. Regulation of TCR-induced protein tyrosine phosphoryla-
tion by PAG. wt, wild type. (A) Overall protein tyrosine phosphoryla-
tion. Thymocytes from the indicated mice were stimulated as outlined
for Fig. 1, except that biotinylated anti-TCR MAb H57-597 plus avidin
was used. Changes in protein tyrosine phosphorylation were monitored
by immunoblotting of total cell lysates with anti-P.tyr antibodies.
(B) Cell fractionation. Cells were stimulated as described for panel A,
except that lysates were fractionated by sucrose density gradient cen-
trifugation. Lysates corresponding to equal cell numbers were ob-
tained from fractions 2 and 3 (lipid raft fractions) or fractions 8 and 9
(soluble fractions) and were probed by immunoblotting with anti-P.tyr
(top panel), anti-LAT (center panel), or anti-PAG (bottom panel)
antibodies. Total cell lysates were analyzed in lanes 13 to 18.
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vated Src kinase. Considering that the aptitude of PAG to
inhibit T-cell activation correlated with its ability to bind Csk
and inhibit proximal TCR signaling events, it was reasonable to
propose that this effect is due to an inactivation of Src kinases.
To test this idea, we examined whether the inhibitory impact of
PAG could be rescued by expression of a Src kinase mutant
that was refractory to Csk-mediated inhibition. To this end,
transgenic mice expressing a mutated version of the Src-related
kinase FynT, in which the inhibitory tyrosine (Y528) is re-
placed by phenylalanine, were created. This mutated Src ki-
nase was selected for these studies because it had been shown
previously to have no appreciable effect on T-cell development
(12). Once generated, mice expressing FynT Y528F were
crossed with those overexpressing wild-type PAG. Adequate
expression of the two transgenes was confirmed by immuno-
blotting of thymocyte lysates with anti-PAG (Fig. 6A, top
panel) or anti-Fyn (bottom panel) antibodies.
CD4 thymocytes from these animals were stimulated with
anti-CD3 plus anti-CD28, and cell proliferation and IL-2 pro-
duction were measured as described for Fig. 3. As expected,
wild-type PAG inhibited the proliferative response to anti-
CD3 plus anti-CD28 (Fig. 6B). A similar effect was seen on
IL-2 release (Fig. 6C). More importantly, while constitutively
activated FynT alone had no measurable impact on these re-
sponses, it abolished the inhibitory influence of wild-type PAG
(Fig. 6B and C). Therefore, these data demonstrated that a
mutant Src kinase that was refractory to Csk-mediated inhibi-
tion was able to bypass the suppressive effect of PAG in normal
T cells.
Regulation of PAG tyrosine phosphorylation by PTPs. Since
tyrosine phosphorylation of PAG appears to be necessary for
its ability to inhibit T-cell activation, we sought to identify the
PTP(s) involved in counteracting this phosphorylation. By de-
phosphorylating PAG, this PTP could presumably have a per-
missive effect in TCR signaling. Several candidates were con-
sidered. First, the proline-rich phosphatases PEP and PTP-
PEST might be involved, given that both have been reported to
bind Csk via the Csk SH3 domain (10, 14). Second, the SH2
domain-containing PTP SHP-1, as well as its relative SHP-2,
might contribute, as SHP-1 was found to be recruited to lipid
rafts in response to TCR stimulation (22). And third, we esti-
mated that CD45 was a candidate, since it is extremely abun-
dant in T-cell membranes and is known to be a positive regu-
lator of TCR signaling (31).
We first ascertained whether these PTPs were present in
lipid raft fractions of T cells (Fig. 7), hypothesizing that the
PTP involved in PAG regulation was likely to accumulate at
least partially in lipid rafts. In agreement with previous reports,
PAG (Fig. 7A, top panel) and GM1 gangliosides (bottom
panel) were present in large quantities in the lipid raft fractions
of mouse thymocytes (lanes 1 to 3). Likewise, 20% of Csk
(center panel) was localized in these fractions, presumably due
to its interaction with PAG. In contrast, PTPs such as PEP
(Fig. 7B, top panel), PTP-PEST (second panel from top),
SHP-1 (third panel from top), and SHP-2 (fourth panel from
top) were present exclusively in the soluble fractions (lanes 5 to
7). This was not the case for CD45 (fifth panel from top),
however, which was detectable in moderate amounts (5 to
10%) in the lipid raft fractions (lanes 1 to 3).
To further examine the nature of the PTP(s) responsible for
PAG dephosphorylation in T cells, thymocytes were isolated
from mice lacking PEP, SHP-1, or CD45 and then cell lysates
were separated by sucrose density gradient centrifugation.
Fractions corresponding to lipid rafts were probed by immu-
noblotting with anti-P.tyr antibodies (Fig. 8A). This experi-
ment revealed that an 80-kDa protein consistent with PAG
was tyrosine phosphorylated to a normal extent in lipid raft
fractions from PEP-deficient (top panel) or SHP-1-deficient
(center panel) thymocytes. However, the phosphotyrosine con-
tent of this product was increased in CD45-deficient thymo-
cytes (bottom panel). Immunoprecipitation with anti-PAG an-
tibodies confirmed that this polypeptide was PAG (Fig. 8B and
C, top panels). The enhanced PAG tyrosine phosphorylation in
CD45-deficient thymocytes was accompanied by an increase in
the amount of PAG-associated Csk (Fig. 8B, center panel).
Next, the involvement of these PTPs in the ability of PAG to
undergo dephosphorylation (Fig. 8C, top panel) and dissociate
FIG. 5. Regulation of TCR-induced calcium fluxes by PAG. Thy-
mocytes were loaded with Indo-1 and were stimulated at 37°C with
biotinylated anti-TCR MAb H57-597 and avidin. Changes in intracel-
lular calcium were monitored, using a cell sorter, by gating on CD4
single-positive thymocytes. The ratio of bound Indo-1/free Indo-1 is
shown on the ordinate. The arrow corresponds to the moment at which
the biotinylated anti-TCR antibody and avidin were present and rep-
resents time 0. Cells were observed for 6 min. Similar results were
obtained when calcium changes were analyzed in total thymocytes
(data not shown). In comparison to normal cells, considerably fewer
cells overexpressing wild-type (wt) PAG exhibited a calcium response
(20.2% versus 4.6%).
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from Csk (center panel) in response to TCR stimulation was
ascertained. We observed that these responses were normal in
thymocytes lacking PEP (lanes 5 and 6) or SHP-1 (lanes 7 and
8). By contrast, there was little or no PAG dephosphorylation
and dissociation from Csk in TCR-stimulated thymocytes lack-
ing CD45 (lanes 3 and 4).
Because thymocyte maturation is arrested at the double-
positive stage in CD45-deficient mice (4, 21), it was possible
that the increased baseline PAG phosphorylation in these an-
imals was due to a change in thymocyte subpopulations. To
help exclude this possibility, PAG tyrosine phosphorylation
was studied in CD45-positive and CD45-negative variants of
the mouse T-cell line YAC-1 (36) (Fig. 8D). As was observed
in CD45-deficient thymocytes (Fig. 8A and 8B), the phospho-
tyrosine content of PAG was prominently increased in CD45-
negative YAC-1 cells (Fig. 8D, top panel, lane 2) compared to
CD45-positive cells (lane 1). A concomitant augmentation of
the association of PAG with Csk was noted (center panel). The
enhanced PAG tyrosine phosphorylation in CD45-negative
YAC-1 cells appeared to be quite selective, as most other
polypeptides found in total cell lysates exhibited no increase in
tyrosine phosphorylation (Fig. 8E).
FIG. 6. Impact of constitutively activated Src kinase on PAG-mediated inhibition. Mice overexpressing wild-type PAG were crossed with
transgenic mice expressing a constitutively activated version of FynT (FynT Y528F). wt, wild type. (A) Expression of PAG and FynT. Lysates from
thymocytes were probed by immunoblotting with anti-PAG (top panel) or anti-Fyn (bottom panel). (B) Thymidine incorporation; (C) IL-2
secretion. Cells were stimulated and assayed as detailed for Fig. 3.
FIG. 7. Cell fractionation experiments. (A and B) Sucrose density gradient centrifugation. The distribution of several molecules in mouse
thymocytes was examined by sucrose density gradient centrifugation. Polypeptides were detected by immunoblotting with the indicated antibodies,
utilizing aliquots obtained from the various fractions. Lipid rafts corresponded to fractions 2 to 4, while soluble proteins were present in fractions
7 to 9. In the case of GM1 gangliosides, detection was achieved using a dot blot and probing of the membrane with cholera toxin (Tx) coupled
to horseradish peroxidase. Similar results were obtained when lysates were prepared with Triton X-100 (data not shown).
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Hence, based on the data of Fig. 7 and 8, it seems unlikely
that PTPs such as PEP, SHP-1, and possibly PTP-PEST and
SHP-2 are involved in inhibiting PAG tyrosine phosphoryla-
tion in T cells. However, it appears that CD45 has a role in this
process. To assess further whether PAG was a direct substrate
of CD45, a substrate-trapping experiment was performed (Fig.
9). This experiment is based on the principle that PTPs, in
which the catalytic site is mutated and rendered inactive, can
stably interact with their substrates in transfected cells (16).
Cos-1 cells were transfected with cDNAs encoding PAG and
activated Lck (to induce PAG tyrosine phosphorylation), in the
presence of either wild-type or inactive CD45. A my-
ristylated form of CD45 (Src-CD45) was used in these studies,
to facilitate the membrane targeting of CD45. Immunoblots of
total cell lysates confirmed that all proteins were adequately
expressed in the transfected cells (Fig. 9A).
This experiment showed that PAG was easily detected in
anti-CD45 immunoprecipitates obtained from cells expressing
the inactive form of CD45 (Fig. 9B, top panel, lane 4) but not
those expressing wild-type CD45 (lane 2). No PAG was found
in immunoprecipitates obtained with normal rabbit serum
(lanes 1 and 3). A similar association was seen between acti-
vated Lck and CD45 (bottom panel), in keeping with the pre-
viously published data indicating that activated Lck is also a
substrate of CD45 (31). Hence, the results of this study sug-
gested that, like Lck, PAG might be a direct target of CD45.
DISCUSSION
In this report, we have examined the function and regulation
of the lipid raft-associated transmembrane adaptor PAG in T
cells. First, as previously reported for human T cells (2, 17, 32),
we observed that PAG was extensively tyrosine phosphorylated
and associated with Csk in ex vivo mouse thymocytes. Further-
more, following antigen receptor stimulation on these cells,
PAG underwent rapid dephosphorylation and became dissoci-
ated from Csk. In time-course analyses, PAG dephosphoryla-
tion temporally coincided with, or perhaps even preceded, the
overall intracellular protein tyrosine phosphorylation signal
induced by TCR engagement. Taken together, these findings
supported the earlier idea that PAG dephosphorylation and
dissociation from Csk are early events of T-cell activation and
FIG. 8. Involvement of PTPs in dephosphorylation of PAG in T cells. (A) Extent of PAG tyrosine phosphorylation in phosphatase-deficient
thymocytes. Thymocytes were isolated from the indicated mice, and lysates were fractionated by sucrose density gradient centrifugation. The extent
of tyrosine phosphorylation of PAG was evaluated by immunoblotting of fractions corresponding to lipid rafts (fractions 2 to 4) with anti-P.tyr
antibodies. (B) PAG tyrosine phosphorylation and association with Csk in CD45-deficient thymocytes. PAG was immunoprecipitated from cell
lysates with anti-PAG, and its phosphotyrosine content was examined by anti-P.tyr immunoblotting (top panel). The extent of association of PAG
with Csk was determined by immunoblotting of anti-Csk immunoprecipitates with anti-PAG (center panel). The abundance of PAG was verified
by immunoblotting of total cell lysates with anti-PAG (bottom panel). (C) TCR-induced dephosphorylation of PAG in phosphatase-deficient
thymocytes. Cells were stimulated for 1 min with biotinylated anti-CD3 MAb 145-2C11 and avidin. Unstimulated controls were incubated with
avidin alone. Tyrosine phosphorylation of PAG was assessed by probing of anti-PAG immunoprecipitates with anti-P.tyr immunoblotting (top
panel). The association with Csk was examined by reprobing the immunoblot membrane with anti-Csk (center panel), whereas the abundance of
PAG was verified by reprobing of the immunoblot with anti-PAG (bottom panel). (D) PAG tyrosine phosphorylation and association with Csk in
a CD45-negative T-cell line. CD45-positive and CD45-negative derivatives of the mouse T-cell line YAC-1 were examined. PAG was immuno-
precipitated from cell lysates with anti-PAG, and its phosphotyrosine content was examined by anti-P.tyr immunoblotting (top panel). The extent
of association of PAG with Csk was determined by immunoblotting of anti-PAG immunoprecipitates with anti-Csk (center panel), while the
abundance of PAG was verified by immunoblotting of anti-PAG immunoprecipitates with anti-PAG (bottom panel). (E) Overall protein tyrosine
phosphorylation in CD45-positive and CD45-negative derivatives of YAC-1. Overall protein tyrosine phosphorylation was determined by immu-
noblotting of total cell lysates with anti-P.tyr antibodies.
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that they might be required for TCR signaling to proceed
normally.
To address the mechanism of action of PAG, wild-type PAG
and phosphorylation-defective PAG mutants were expressed
in normal mouse T cells via transgenesis. Our analyses of these
mice revealed that overexpression of wild-type PAG caused a
striking inhibition of TCR-induced proliferation and IL-2 pro-
duction. This effect was observed in several T-cell populations,
namely, CD4 splenic T cells, CD8 splenic T cells, CD4
thymocytes, and CD4 lymph node T cells. In contrast to
wild-type PAG, the phosphorylation-defective PAG mutants
PAG Y314F and PAG 9Y3F caused an enhancement of these
TCR-triggered responses. In addition to demonstrating the
importance of tyrosine phosphorylation for the inhibitory func-
tion of PAG, the dominant-negative effect of these mutants
implied that the inhibitory impact of wild-type PAG was not a
spurious effect of overexpression. Rather, it reflected the true
function of endogenous PAG molecules.
Several lines of evidence indicated that PAG inhibits T-cell
activation primarily by recruiting Csk and inactivating Src ki-
nases. First, we found that the inhibitory influence of PAG was
eliminated by mutation of Y314, the major Csk-binding site of
PAG (20, 30). Obviously, the possibility that this site was also
implicated in recruiting other SH2 domain-containing mole-
cules to PAG cannot be excluded. Second, it was noted that
augmented PAG expression resulted in an inhibition of TCR-
induced protein tyrosine phosphorylation, an effect analogous
to that observed upon overexpression of Csk (8). And lastly,
PAG-mediated inhibition was rescued by expression of a Src
kinase mutant that is refractory to the effect of Csk (FynT
Y528F). While this last finding is in keeping with our model, it
is worth mentioning that the activated FynT might also func-
tion by causing enhanced phosphorylation of proteins other
than PAG.
While PAG overexpression inhibited TCR-induced prolifer-
ation and IL-2 secretion, it is noteworthy that it had no impact
on the production of IL-4 and IFN-. This finding suggested
that the intensity and/or nature of the TCR signals required for
release of IL-2 and proliferation might be distinct from those
needed for production of IL-4 and IFN-. Interestingly, a sim-
ilar alteration in the profile of cytokine production was re-
ported for anergic T cells. Like PAG-overexpressing cells,
these cells have severe defects in TCR-induced proliferation
and IL-2 secretion but tend to exhibit normal secretion of IL-4
or IFN- (1, 15). This qualitative difference was proposed to
reflect a hierarchy in the TCR signaling thresholds required for
production of the various cytokines (18). It is possible that a
similar phenomenon explains the differential effects of PAG on
cytokine production. Given the similarities between anergic
and PAG-overexpressing T cells, it is also tempting to specu-
late that PAG is involved in the pathophysiology of T-cell
anergy.
A surprising finding in our studies was that expression of the
dominant-negative PAG molecules had no appreciable effect
on thymocyte development. This is in striking contrast to the
previously described severe effects of Csk deficiency on T-cell
maturation (29). A possible explanation for this distinction is
that PAG-independent mechanisms exist for membrane re-
cruitment of Csk. Along these lines, it was reported that the
Csk SH2 domain can interact with other molecules such as
Dok-related adaptors, paxillin, and focal adhesion kinase (35).
Alternatively, the expression levels of the phosphorylation-
defective PAG polypeptides might have been insufficient to
obliterate fully the physiological function of endogenous PAG
molecules. While the creation of PAG-deficient mouse T cells
should help distinguish between these possibilities, it seems
probable, based on the available evidence, that additional
mechanisms of Csk recruitment exist.
Considering the importance of PAG tyrosine phosphoryla-
tion for its inhibitory function, we attempted to identify the
PTPs regulating this process. By analyzing T cells lacking var-
ious PTPs, evidence was adduced that PEP and SHP-1 were
not involved in controlling PAG tyrosine phosphorylation. The
lack of effect of PEP on PAG tyrosine phosphorylation was
also confirmed by analyses of transgenic mice overexpressing
wild-type PEP or phosphatase-inactive versions of PEP (our
unpublished results). The observation that PEP had no appar-
ent effect on PAG tyrosine phosphorylation was unexpected,
FIG. 9. Substrate-trapping experiment. Cos-1 cells were transiently transfected with the indicated cDNAs, as detailed in the text. (A) Expres-
sion levels of the various polypeptides. The abundance of PAG (top panel), SH2 Y505F Lck (center panel) and the two Src-CD45 variants
(bottom panel) in total cell lysates was assessed by immunoblotting with the indicated antibodies. (B) Association of PAG with inactive, but not
active, CD45. Lysates were immunoprecipitated with the specified antisera and then probed by immunoblotting with the indicated antibodies. NRS,
normal rabbit serum.
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given that PEP associates with Csk by way of the Csk SH3
domain (10). Nonetheless, we recently obtained indications
that the pool of Csk molecules associated with PEP does not
interact simultaneously with PAG (our unpublished results).
Therefore, PAG might not be accessible to PEP-mediated
dephosphorylation.
However, our results provided an indication that CD45 is
involved in inhibiting PAG tyrosine phosphorylation in T cells.
In support of this idea, CD45, but not PTPs like PEP and
SHP-1, partially colocalized with PAG in lipid raft fractions.
Moreover, we found that the phosphotyrosine content of PAG
was increased in lipid raft fractions of CD45-deficient thymo-
cytes as well as in a CD45-negative variant of the mouse T-cell
line YAC-1. While it is impossible with the currently available
technologies to prove that CD45 was acting directly on PAG,
this notion was suggested by the finding that a substrate-trap-
ping mutant of CD45 can interact with tyrosine-phosphory-
lated PAG in transiently transfected Cos-1 cells. On the other
hand, it is also plausible that CD45 regulated PAG phosphor-
ylation by an indirect mechanism, for instance by inactivating
Src kinases through dephosphorylation of their activating ty-
rosine (31). The development of new methodologies capable of
identifying enzyme-substrate interactions in vivo is needed to
resolve these issues. Lastly, it should be pointed out that, in
addition to CD45, other PTPs are likely to be involved in
regulating PAG tyrosine phosphorylation. This is definitely
true for nonhemopoietic cells, which express PAG but lack
CD45.
The finding that CD45 is involved, directly or indirectly, in
regulating PAG tyrosine phosphorylation is likely to be impor-
tant. It suggests that CD45 sets the threshold of TCR signaling
by at least two mechanisms. First, as documented in the past,
CD45 dephosphorylates the inhibitory tyrosine of Src kinases
(31). And second, as reported herein, it promotes the dephos-
phorylation of PAG, thereby diminishing the amount of Csk
located in lipid rafts. Both effects converge on increasing the
catalytic activity of Src kinases, and their combination might be
critical to the generation of sufficient Src kinase activation to
allow productive TCR signaling to occur.
In summary, the data reported in this work provide compel-
ling evidence that PAG is a negative regulator of T-cell acti-
vation in normal T cells as a result of its capacity to recruit Csk
and inactivate Src kinases. They also support the idea that the
dephosphorylation of PAG is a pivotal event during the initi-
ation of T-cell activation. In the light of these results, addi-
tional studies are warranted to elucidate the mechanism re-
sponsible for PAG dephosphorylation upon TCR engagement.
One possibility is that TCR stimulation activates or alters the
cellular localization of PTPs like CD45 and others. Alterna-
tively, triggering of the TCR might inactivate or sequester the
PTK(s) responsible for PAG phosphorylation. An understand-
ing of this phenomenon would undoubtedly provide valuable
insights into the molecular changes responsible for initiating
T-cell activation.
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